Published in Eur J Radiol Open on March 16, 2015
A comprehensive literatures update of clinical researches of superparamagnetic resonance iron oxide nanoparticles for magnetic resonance imaging. Quant Imaging Med Surg (2017) 1.38
The value of advanced MRI techniques in the assessment of cervical cancer: a review. Insights Imaging (2017) 0.75
Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics (1988) 70.41
Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer--a meta-analysis. Clin Oncol (R Coll Radiol) (2002) 3.33
Comparisons of predictive values of binary medical diagnostic tests for paired designs. Biometrics (2000) 2.45
Ultrasmall superparamagnetic particles of iron oxide allow for the detection of metastases in normal sized pelvic lymph nodes of patients with bladder and/or prostate cancer. Eur J Cancer (2012) 2.15
Carcinoma of the cervix treated with radiation therapy. I. A multi-variate analysis of prognostic variables in the Gynecologic Oncology Group. Cancer (1991) 1.85
Metastases in normal-sized pelvic lymph nodes: detection with diffusion-weighted MR imaging. Radiology (2014) 1.78
Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. Cochrane Database Syst Rev (2005) 1.65
Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: a final report of the 1973 and 1978 patterns of care studies. Int J Radiat Oncol Biol Phys (1991) 1.62
Lymph node metastases from head and neck squamous cell carcinoma: MR imaging with ultrasmall superparamagnetic iron oxide particles (Sinerem MR) -- results of a phase-III multicenter clinical trial. Eur Radiol (2001) 1.60
Radiological evaluation of lymph node metastases in patients with cervical cancer. A meta-analysis. JAMA (1997) 1.56
Prostate cancer: detection of lymph node metastases outside the routine surgical area with ferumoxtran-10-enhanced MR imaging. Radiology (2009) 1.34
The prognostic significance of number of positive nodes in cervical carcinoma stages IB, IIA, and IIB. Cancer (1990) 1.32
Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. J Clin Oncol (2005) 1.22
Superparamagnetic iron oxide-enhanced MR imaging of head and neck lymph nodes. Radiology (2002) 1.05
Preoperative breast cancer staging: MR imaging of the axilla with ultrasmall superparamagnetic iron oxide enhancement. Radiology (2002) 1.04
Ferumoxtran-10-enhanced MR lymphangiography: does contrast-enhanced imaging alone suffice for accurate lymph node characterization? AJR Am J Roentgenol (2006) 0.98
MR lymphangiography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: radiographic-pathologic correlation. AJR Am J Roentgenol (1999) 0.97
Impact of dose in outcome of irradiation alone in carcinoma of the uterine cervix: analysis of two different methods. Int J Radiat Oncol Biol Phys (1991) 0.93
Diagnostic performance of USPIO-enhanced MRI for lymph-node metastases in different body regions: a meta-analysis. Eur J Radiol (2010) 0.85
Radiotherapy alone in carcinoma of the intact uterine cervix according to G. H. Fletcher guidelines: a French cooperative study of 1383 cases. Int J Radiat Oncol Biol Phys (1988) 0.85
MR imaging of mediastinal lymph nodes: evaluation using a superparamagnetic contrast agent. J Magn Reson Imaging (2000) 0.84
Exploratory celiotomy for surgical staging of cervical cancer. Am J Obstet Gynecol (1972) 0.84
Survival after extraperitoneal pelvic and paraaortic lymphadenectomy and radiation therapy in cervical carcinoma. Obstet Gynecol (1981) 0.82
Surgical predictors of para-aortic metastases in early-stage cervical carcinoma. Gynecol Oncol (1995) 0.81
Diagnostic tests for gastrocnemius tightness. J Bone Joint Surg Am (2003) 0.80